home news forum careers events suppliers solutions markets expos directories catalogs resources advertise contacts
 
News Page

The news
and
beyond the news
Index of news sources
All Africa Asia/Pacific Europe Latin America Middle East North America
  Topics
  Species
Archives
News archive 1997-2008
 

Trana Discovery and Bayer collaborate to develop novel fungicides


Cary, North Carolina, USA
Janjuary 23, 2017

Trana Discovery, Inc., Cary, North Carolina, USA today announced a collaboration agreement with Bayer to discover and validate new fungicides to protect food crops against plant diseases responsible for hundreds of millions of dollars in annual crop losses worldwide. Trana Discovery identifies molecules that inhibit the target pathogen(s) ability to use an organism-specific RNA molecule essential for fungal propagation.

The technology platform developed by Trana Discovery is the basis to discover novel targets for antifungal compounds that inhibit an RNA molecule specific to a targeted pathogen. This RNA molecule is essential for normal pathogen replication and compounds that can block the function of this molecule have the potential to be developed into new antifungals.

“Development of this new class of fungicides possessing a profile of targeted elimination of the harmful fungi while sparing beneficial organisms will give Bayer an industry leading approach to pesticide application,” said Steve Peterson, Chief Executive Officer of Trana Discovery.

Plants are exposed to a wide range of both biotic and abiotic stresses which have a significant impact on world agriculture. Trana Discovery has already successfully demonstrated its discovery technology.  This agreement allows Trana Discovery and Bayer to leverage their combined knowledge to develop innovative solutions which increase agricultural productivity in a sustainable manner.

About Trana Discovery, Inc.

Trana Discovery provides a proprietary anti-infective discovery technology platform that enables its partners to discover new treatments of bacterial, viral, and fungal infectious diseases. Our assays screen compounds to identify potential anti-infective candidates that work through a novel mechanism of action: inhibition of the target pathogen(s) ability to use an organism-specific transfer RNA (tRNA), essential for propagation. The company is located in Cary, North Carolina. For more information, please visit www.tranadiscovery.com .

About Bayer

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen.  For more information, go to www.bayer.com.



More news from:
    . Trana Discovery Inc.
    . Bayer CropScience LP (U.S.)


Website: http://www.tranadiscovery.com

Published: February 9, 2017

The news item on this page is copyright by the organization where it originated
Fair use notice


Copyright @ 1992-2025 SeedQuest - All rights reserved